$4.07 Billion is the total value of Candriam S.C.A.'s 617 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ISSI | INTEGRATED SILICON SOLUTION | $11,128,000 | -2.9% | 517,800 | 0.0% | 0.27% | +14.2% | |
NEWMONT MINING CORPnote 1.625% 7/1 | $9,951,000 | -3.1% | 10,000 | 0.0% | 0.24% | +14.0% | ||
YAHOO INCnote 12/0 | $6,801,000 | -4.9% | 7,000 | 0.0% | 0.17% | +12.1% | ||
ARES CAP CORPnote 5.750% 2/0 | $6,008,000 | -2.4% | 5,900 | 0.0% | 0.15% | +15.6% | ||
OMG | OM GROUP INC | $4,859,000 | -2.1% | 147,725 | 0.0% | 0.12% | +15.5% | |
ARES CAP CORPnote 4.375% 1/1 | $3,144,000 | +0.2% | 3,000 | 0.0% | 0.08% | +18.5% | ||
QIHOO 360 TECHNOLOGY CO LTDnote 2.500% 9/1 | $2,880,000 | -2.8% | 3,000 | 0.0% | 0.07% | +14.5% | ||
TRILLIUM THERAPEUTICS INC | $1,354,000 | -43.1% | 110,000 | 0.0% | 0.03% | -34.0% | ||
INFY | INFOSYS LTDsponsored adr | $1,069,000 | +20.4% | 56,000 | 0.0% | 0.03% | +44.4% | |
DTE | DTE ENERGY CO | $1,017,000 | +7.7% | 12,649 | 0.0% | 0.02% | +25.0% | |
RDHL | REDHILL BIOPHARMA LTDsponsored ads | $920,000 | -26.7% | 71,267 | 0.0% | 0.02% | -11.5% | |
VIVO | MERIDIAN BIOSCIENCE INC | $787,000 | -8.2% | 46,000 | 0.0% | 0.02% | +5.6% | |
SPLK | SPLUNK INC | $703,000 | -20.5% | 12,700 | 0.0% | 0.02% | -5.6% | |
DISH | DISH NETWORK CORPcl a | $644,000 | -13.9% | 11,041 | 0.0% | 0.02% | 0.0% | |
PANW | PALO ALTO NETWORKS INC | $619,000 | -1.6% | 3,600 | 0.0% | 0.02% | +15.4% | |
TRI | THOMSON REUTERS CORP | $576,000 | +5.1% | 14,385 | 0.0% | 0.01% | +27.3% | |
FMI | FOUNDATION MEDICINE INC | $554,000 | -45.4% | 30,000 | 0.0% | 0.01% | -33.3% | |
HCBK | HUDSON CITY BANCORP | $492,000 | +2.9% | 48,389 | 0.0% | 0.01% | +20.0% | |
ODP | OFFICE DEPOT INC | $449,000 | -25.9% | 70,000 | 0.0% | 0.01% | -15.4% | |
NEOVASC INC | $410,000 | -22.2% | 77,000 | 0.0% | 0.01% | -9.1% | ||
CDK | CDK GLOBAL INC | $388,000 | -11.4% | 8,112 | 0.0% | 0.01% | +11.1% | |
HOG | HARLEY DAVIDSON INC | $399,000 | -2.7% | 7,276 | 0.0% | 0.01% | +11.1% | |
PBRA | PETROLEO BRASILEIRO SA PETROsp adr non vtg | $408,000 | -54.9% | 110,950 | 0.0% | 0.01% | -47.4% | |
LPX | LOUISIANA PAC CORP | $384,000 | -16.5% | 27,000 | 0.0% | 0.01% | -10.0% | |
GNMK | GENMARK DIAGNOSTICS INC | $354,000 | -13.2% | 45,000 | 0.0% | 0.01% | +12.5% | |
IAC | IAC INTERACTIVECORP | $352,000 | -18.1% | 5,400 | 0.0% | 0.01% | 0.0% | |
KIM | KIMCO RLTY CORP | $276,000 | +8.2% | 11,304 | 0.0% | 0.01% | +40.0% | |
NWSA | NEWS CORP NEWcl a | $300,000 | -13.5% | 23,788 | 0.0% | 0.01% | 0.0% | |
PWR | QUANTA SVCS INC | $267,000 | -15.8% | 11,010 | 0.0% | 0.01% | 0.0% | |
CF | CF INDS HLDGS INC | $296,000 | -30.2% | 6,591 | 0.0% | 0.01% | -22.2% | |
SLAB | SILICON LABORATORIES INC | $237,000 | -23.1% | 5,700 | 0.0% | 0.01% | 0.0% | |
XEC | CIMAREX ENERGY CO | $239,000 | -7.0% | 2,332 | 0.0% | 0.01% | +20.0% | |
KLAC | KLA-TENCOR CORP | $252,000 | -11.0% | 5,043 | 0.0% | 0.01% | 0.0% | |
GOLD | BARRICK GOLD CORP | $190,000 | -40.8% | 30,030 | 0.0% | 0.01% | -28.6% | |
LNG | CHENIERE ENERGY INC | $206,000 | -30.2% | 4,264 | 0.0% | 0.01% | -16.7% | |
EWH | ISHARESmsci hong kg etf | $192,000 | -15.0% | 10,017 | 0.0% | 0.01% | 0.0% | |
NAVI | NAVIENT CORP | $129,000 | -38.3% | 11,501 | 0.0% | 0.00% | -25.0% | |
TGA | TRANSGLOBE ENERGY CORP | $130,000 | -34.7% | 50,000 | 0.0% | 0.00% | -25.0% | |
PBR | PETROLEO BRASILEIRO SA PETROsponsored adr | $91,000 | -51.9% | 20,920 | 0.0% | 0.00% | -50.0% | |
CRC | CALIFORNIA RES CORP | $29,000 | -56.7% | 11,071 | 0.0% | 0.00% | 0.0% | |
AUY | YAMANA GOLD INC | $19,000 | -45.7% | 11,610 | 0.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-10-19
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 39 | Q2 2024 | 6.7% |
MERCK & CO INC NEW | 39 | Q2 2024 | 2.6% |
GILEAD SCIENCES INC | 39 | Q2 2024 | 3.1% |
REGENERON PHARMACEUTICALS | 39 | Q2 2024 | 2.0% |
PROCTER & GAMBLE CO | 39 | Q2 2024 | 1.9% |
JOHNSON & JOHNSON | 39 | Q2 2024 | 2.5% |
BIOGEN INC | 39 | Q2 2024 | 2.6% |
VERTEX PHARMACEUTICALS INC | 39 | Q2 2024 | 2.1% |
META PLATFORMS INC | 39 | Q2 2024 | 1.6% |
VISA INC | 39 | Q2 2024 | 1.4% |
View Candriam S.C.A.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-16 |
13F-HR | 2024-08-05 |
13F-HR | 2024-05-06 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-03 |
View Candriam S.C.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.